Sakaityte A, cesnaviciute I, Raudonis T
Clin Pract. 2024; 14(5):1696-1706.
PMID: 39311285
PMC: 11417930.
DOI: 10.3390/clinpract14050135.
Raudonis T, Sakaityte A, Vileikis T, Cernel V, Ganceviciene R, Zouboulis C
J Clin Med. 2024; 13(13).
PMID: 38999466
PMC: 11242771.
DOI: 10.3390/jcm13133900.
Chiang N, Sibbald C, Levy R, Lara-Corrales I
Paediatr Drugs. 2023; 25(6):659-676.
PMID: 37782437
DOI: 10.1007/s40272-023-00595-6.
Lipa K, Zajac N, Witkowski G, Ciechanowicz P, Wiszniewski K, Szymanska E
Postepy Dermatol Alergol. 2023; 40(4):518-528.
PMID: 37692279
PMC: 10485753.
DOI: 10.5114/ada.2021.112075.
Alhusain A, Almosa A, Alqirnas M, Alissa S
J Surg Case Rep. 2023; 2023(6):rjad318.
PMID: 37397067
PMC: 10308003.
DOI: 10.1093/jscr/rjad318.
Surgical Management of Hidradenitis Suppurativa: Factors Associated with Postoperative Complications and Disease Recurrence.
Skorochod R, Margulis A, Adler N
Plast Reconstr Surg Glob Open. 2023; 11(1):e4752.
PMID: 36776589
PMC: 9911192.
DOI: 10.1097/GOX.0000000000004752.
Antibiotic Treatment for Hidradenitis Suppurativa in France: A Practice Survey.
Fougerousse A, Maccari F, Guillem P, Reguiai Z
Clin Cosmet Investig Dermatol. 2022; 15:2641-2645.
PMID: 36523542
PMC: 9744862.
DOI: 10.2147/CCID.S374643.
Efficacy of Subantimicrobial, Modified-Release Doxycycline Compared to Regular-Release Doxycycline for the Treatment of Hidradenitis Suppurativa.
Kontochristopoulos G, Tsiogka A, Agiasofitou E, Kapsiocha A, Soulaidopoulos S, Liakou A
Skin Appendage Disord. 2022; 8(6):476-481.
PMID: 36407641
PMC: 9672876.
DOI: 10.1159/000524762.
Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.
Ingram J, Bettoli V, Espy J, Kokolakis G, Martorell A, Villani A
J Eur Acad Dermatol Venereol. 2022; 36(9):1597-1605.
PMID: 35445469
PMC: 9545202.
DOI: 10.1111/jdv.18163.
Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice.
Orenstein L, Nguyen T, Damiani G, Sayed C, Jemec G, Hamzavi I
Dermatology. 2020; 236(5):393-412.
PMID: 32408306
PMC: 8177083.
DOI: 10.1159/000507323.
Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm.
Seyed Jafari S, Hunger R, Schlapbach C
Front Med (Lausanne). 2020; 7:68.
PMID: 32195261
PMC: 7064439.
DOI: 10.3389/fmed.2020.00068.
The Role of the Cutaneous Microbiome in Hidradenitis Suppurativa-Light at the End of the Microbiological Tunnel.
Langan E, Recke A, Bokor-Billmann T, Billmann F, Kahle B, Zillikens D
Int J Mol Sci. 2020; 21(4).
PMID: 32054085
PMC: 7072827.
DOI: 10.3390/ijms21041205.
Miscellaneous Perianal Afflictions.
Hagerman G, Silva-Velazco J, Molina-Lopez J
Clin Colon Rectal Surg. 2019; 32(5):394-402.
PMID: 31507350
PMC: 6731119.
DOI: 10.1055/s-0039-1687836.
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.
Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C
J Am Acad Dermatol. 2019; 81(1):91-101.
PMID: 30872149
PMC: 9131892.
DOI: 10.1016/j.jaad.2019.02.068.
Are Bacteria Infectious Pathogens in Hidradenitis Suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017.
Naik H, Nassif A, Ramesh M, Schultz G, Piguet V, Alavi A
J Invest Dermatol. 2018; 139(1):13-16.
PMID: 30414909
PMC: 8171295.
DOI: 10.1016/j.jid.2018.09.036.
Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
Zouboulis C, Bechara F, Dickinson-Blok J, Gulliver W, Horvath B, Hughes R
J Eur Acad Dermatol Venereol. 2018; 33(1):19-31.
PMID: 30176066
PMC: 6587546.
DOI: 10.1111/jdv.15233.
Hidradenitis Suppurativa in Kuala Lumpur, Malaysia: A 7-Year Retrospective Review.
Kamil M, Affandi A
Dermatol Res Pract. 2018; 2018:2017959.
PMID: 29951091
PMC: 5987333.
DOI: 10.1155/2018/2017959.
The effect of oral clindamycin and rifampicin combination therapy in patients with hidradenitis suppurativa in Singapore.
Ochi H, Tan L, Oon H
Clin Cosmet Investig Dermatol. 2018; 11:37-39.
PMID: 29403298
PMC: 5779281.
DOI: 10.2147/CCID.S136730.
[Drug therapy of acne inversa].
Schneider-Burrus S, Arpa E, Kors C, Stavermann T, Sabat R, Kokolakis G
Hautarzt. 2017; 69(1):58-63.
PMID: 29234829
DOI: 10.1007/s00105-017-4094-1.
Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review.
Scuderi N, Monfrecola A, Dessy L, Fabbrocini G, Megna M, Monfrecola G
Skin Appendage Disord. 2017; 3(2):95-110.
PMID: 28560220
PMC: 5436059.
DOI: 10.1159/000462979.
